Section » Featured
Patent Attorney, Bob Siminski, Scheduled for Pharma IPR Conference in India
January 31 – February 2 Harness Dickey attorney Robert Siminski will be attending the Pharma IPR conference in Mumbai, India – January 31.-Feb.2. The conference is intended to bring pharmaceutical patent attorneys together from all over the world to discuss issues relevant to the pharmaceutical industry. You are invited to follow Mr.
More Articles
USPTO Issues 239346 Trademark Registrations on 2011
The USPTO issued 239346 trademark registrations in 2011. The most active trademark classes are Class 9 – scientific and electronic apparatus (24,590); Class 16 – printed matter (9692); Class 25 – clothing (14,355). The most active service mark classes are Class 35 – advertising and business (26,542);
Robert Siminski, Contributing Author of The Innovation Superstar Workbook
Troy Attorney, Robert Siminski, was recently published as contributing author to The Innovation Superstar Workbook. Robert joined together with author, Nicholas Webb, to write this book focused on innovation. Nicholas Webb describes his book: “The
Bob Siminski Gets Insight from the Korean Patent Court
Today I met with the Korean Patent Court (KPC), which is essentially equivalent to the U.S. Court of Appeals for the Federal Circuit (CAFC). Despite its name, the KPC has jurisdiction over a wide variety of intellectual property matters, including copyrights, trademarks, and trade secrets, for example. The
Bob Siminski Meets with The Supreme People’s Court in Asia
Today I had the privilege of meeting with five Justices of The Supreme People’s Court. The Justices were very engaging and did a great job educating our group on procedural issues. We discussed everything from injunctive relief to evidentiary considerations. The Justices were asked why there appears
Bob Siminski’s First Meeting in Asia
This morning I met with a delegation of the State Intellectual Property Office led by Deputy Commissioner Yang Tiejun in Beijing. He participated in a question and answer session covering various topics. Some of the more interesting questions and answers were as follows: Q: Due
Patent Attorney, Bob Siminski, Scheduled for Asia Trip with IPO
From Oct. 29 – Nov.5 Harness Dickey attorney Robert (Bob) Siminski will a delegate of
CyberSource v. Retail Decisions, Inc.
In CyberSource v. Retail Decisions, Inc., No. 2009-1358 (August 16, 2011), the Federal Circuit held that an Internet-related method claim and a “computer readable medium” claim both fail to recite patent-eligible subject matter under 35 U.S.C. § 101, potentially calling into question the validity
The Cost of Sloppy Claim Drafting
In CBT Flint Partners, LLC v. Return Path, Inc., No. 2010-1202, -1203 (Fed. Cir. August 10, 2011), CBT appealed a district court’s judgment that a claim was invalid as indefinite. The claim was for an apparatus comprising a network computer “programmed to detect analyze the electronic mail communication
CAFC MYRIAD DECISION: This is Not a “Gene Patent” Case
The panel decision in AMP v. Myriad Genetics, written by Judge Lourie, contained law and fact rulings consistent with the Amicus Brief submitted by HDP on behalf of Gilead Sciences, Inc., Biogenerator and Elan Pharmaceuticals, Inc. The CAFC held that a synthetic cDNA construct is patent-eligible